- €1.89bn
- €2.83bn
- €1.16bn
Brief: Dermapharm Holding Binding Offer To Acquire Arkopharma Group
German stocks - Factors to watch on June 2
Brief: Dermapharm Confirms FY 2022 Outlook
'Poor start to the year': Dermapharm dives on Q1 miss
Brief: Dermapharm Holding: Q1 Consolidated Revenue Up 9.1% At EUR 231.6 Mln
German stocks - Factors to watch on April 14
Brief: Dermapharm Holding: FY Consolidated Revenue Up At EUR 942.9 Mln
Dermapharm Holding slips after outlook misses expectations
Brief: Dermapharm Holding: FY Adjusted Group EBITDA Up At 3-7%
Brief: Dermapharm Holding FY Adjusted Group EBITDA Up At EUR 351 Mln
Brief: Dermapharm Acquires C³ Group
Europe Research Roundup: Darktrace, Johnson Matthey, Santander
Europe Research Roundup: Boohoo, Dunelm Group, Severn Trent
Brief: Dermapharm Holding Raises EBITDA Forecast For The Full Year 2021
Pot producer Canopy to sell German pharma unit C3 on COVID-19 hit (updated)
Canopy Growth hits four-year low, co to sell its German medical marijuana business
Pot producer Canopy Growth to sell German medical marijuana business
Brief: Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company
Brief: Dermapharm Acquisition Of C³ Cannabinoid Compound Company GmbH